Jeff Yass’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $96.6M | Buy |
644,138
+568,149
| +748% | +$61.8M | 0.01% | 989 |
|
|
2026
Q1 | $7.02M | Buy |
75,989
+72,683
| +2,199% | +$7.3M | ﹤0.01% | 3657 |
|
|
2025
Q4 | $338K | Sell |
3,306
-28,380
| -90% | -$2.54M | ﹤0.01% | 9672 |
|
|
2025
Q3 | $1.98M | Sell |
31,686
-151,718
| -83% | -$8.25M | ﹤0.01% | 5819 |
|
|
2025
Q2 | $9.54M | Sell |
183,404
-12,140
| -6% | -$542K | ﹤0.01% | 2897 |
|
|
2025
Q1 | $8.33M | Buy |
195,544
+143,710
| +277% | +$6.2M | ﹤0.01% | 2778 |
|
|
2024
Q4 | $1.58M | Sell |
51,834
-22,220
| -30% | -$625K | ﹤0.01% | 5827 |
|
|
2024
Q3 | $1.7M | Buy |
+74,054
| New | +$2.1M | ﹤0.01% | 5620 |
|
|
2024
Q2 | – | Sell |
-223,585
| Closed | -$5.21M | – | 12451 |
|
|
2024
Q1 | $4.61M | Buy |
223,585
+68,740
| +44% | +$1.47M | ﹤0.01% | 3758 |
|
|
2023
Q4 | $4.19M | Sell |
154,845
-38,086
| -20% | -$999K | ﹤0.01% | 4014 |
|
|
2023
Q3 | $5.72M | Buy |
192,931
+51,782
| +37% | +$1.82M | ﹤0.01% | 3309 |
|
|
2023
Q2 | $5.05M | Sell |
141,149
-203,533
| -59% | -$5.85M | ﹤0.01% | 3519 |
|
|
2023
Q1 | $8.08M | Buy |
344,682
+195,496
| +131% | +$5.58M | ﹤0.01% | 2764 |
|
|
2022
Q4 | $4.06M | Buy |
149,186
+104,660
| +235% | +$4.79M | ﹤0.01% | 3558 |
|
|
2022
Q3 | $2.4M | Sell |
44,526
-86,270
| -66% | -$4.43M | ﹤0.01% | 4563 |
|
|
2022
Q2 | $5.28M | Buy |
130,796
+92,569
| +242% | +$4.59M | ﹤0.01% | 3100 |
|
|
2022
Q1 | $2.53M | Sell |
38,227
-7,208
| -16% | -$493K | ﹤0.01% | 4957 |
|
|
2021
Q4 | $4.54M | Buy |
45,435
+42,754
| +1,595% | +$4.42M | ﹤0.01% | 3911 |
|
|
2021
Q3 | $335K | Buy |
+2,681
| New | +$319K | ﹤0.01% | 10336 |
|
|
2021
Q2 | – | Sell |
-1,761
| Closed | -$237K | – | 12797 |
|
|
2021
Q1 | $269K | Sell |
1,761
-3,530
| -67% | -$534K | ﹤0.01% | 10830 |
|
|
2020
Q4 | $682K | Buy |
5,291
+3,046
| +136% | +$350K | ﹤0.01% | 7610 |
|
|
2020
Q3 | $251K | Sell |
2,245
-188,270
| -99% | -$17.2M | ﹤0.01% | 9057 |
|
|
2020
Q2 | $15.5M | Buy |
190,515
+98,419
| +107% | +$7.93M | ﹤0.01% | 1672 |
|
|
2020
Q1 | $6.41M | Sell |
92,096
-81,310
| -47% | -$6.24M | ﹤0.01% | 2258 |
|
|
2019
Q4 | $13.6M | Sell |
173,406
-49,106
| -22% | -$3.54M | ﹤0.01% | 1785 |
|
|
2019
Q3 | $14.2M | Buy |
222,512
+139,931
| +169% | +$12.3M | ﹤0.01% | 1628 |
|
|
2019
Q2 | $7.13M | Buy |
82,581
+41,246
| +100% | +$3.15M | ﹤0.01% | 2275 |
|
|
2019
Q1 | $3.17M | Buy |
+41,335
| New | +$2.29M | ﹤0.01% | 3050 |
|
Other funds holding GH
DTC
Jeff Yass's GH Position: Q2 2026 in Review
Jeff Yass increased its Guardant Health (GH) stake by 748% in Q2 2026, buying an estimated $61.8M and bringing the position to 644,138 shares worth $96.6M. The position accounts for 0.01% of the portfolio, ranked #989.
Jeff Yass first reported a position in GH in Q1 2019 and has held it in 28 quarters since. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Jeff Yass held 644,138 shares of Guardant Health worth $96.6M as of Q2 2026.
- Jeff Yass bought 568,149 Guardant Health shares in Q2 2026, an estimated $61.8M.
- Guardant Health made up 0.01% of Jeff Yass's portfolio in Q2 2026, its #989 holding.
- Jeff Yass first reported a position in Guardant Health in Q1 2019 and has held it in 28 quarters since.
- 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.